Literature DB >> 9557739

PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.

M O Gold1, X Yang, C H Herrmann, A P Rice.   

Abstract

The human cdc2-related kinase PITALRE is the catalytic component of TAK, the Tat-associated kinase. Previously, we have proposed that TAK is a cellular factor that mediates Tat transactivation function. Here we demonstrate that transient overexpression of PITALRE specifically squelches Tat-1 activation of both a transfected and an integrated human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR), suggesting that PITALRE mediates Tat function as a multiprotein complex. A catalytic mutant of PITALRE, D167N, was found to be more efficient than wild-type PITALRE in squelching Tat transactivation. Neither wild-type PITALRE nor D167N was able to squelch transactivation of the human T-cell leukemia type 1 LTR by the Tax protein. Additionally, we show that artificial targeting of PITALRE to a nascent RNA element, in the absence of Tat, activated HIV-1 LTR expression. These results indicate that a PITALRE-containing complex mediates transactivation by Tat and suggest that Tat proteins function by localizing such a PITALRE-containing complex to the site of the transcribing provirus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557739      PMCID: PMC109679          DOI: 10.1128/JVI.72.5.4448-4453.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.

Authors:  C H Herrmann; A P Rice
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

2.  A kinase-cyclin pair in the RNA polymerase II holoenzyme.

Authors:  S M Liao; J Zhang; D A Jeffery; A J Koleske; C M Thompson; D M Chao; M Viljoen; H J van Vuuren; R A Young
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

3.  Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation.

Authors:  T O'Brien; S Hardin; A Greenleaf; J T Lis
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

4.  Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.

Authors:  H Rhim; A P Rice
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

Review 5.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

6.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.

Authors:  X Graña; A De Luca; N Sang; Y Fu; P P Claudio; J Rosenblatt; D O Morgan; A Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.

Authors:  S J Madore; B R Cullen
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

9.  Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast.

Authors:  S Kuchin; P Yeghiayan; M Carlson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Novel mechanism and factor for regulation by HIV-1 Tat.

Authors:  Q Zhou; P A Sharp
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

View more
  51 in total

1.  Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.

Authors:  F Demarchi; M I Gutierrez; M Giacca
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  Mechanism and regulation of transcriptional elongation by RNA polymerase II.

Authors:  D Reines; R C Conaway; J W Conaway
Journal:  Curr Opin Cell Biol       Date:  1999-06       Impact factor: 8.382

3.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication.

Authors:  O Flores; G Lee; J Kessler; M Miller; W Schlief; J Tomassini; D Hazuda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 5.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication.

Authors:  Sara Richter; Yueh-Hsin Ping; Tariq M Rana
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

7.  A nucleolar TAR decoy inhibitor of HIV-1 replication.

Authors:  Alessandro Michienzi; Shirley Li; John A Zaia; John J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

8.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.

Authors:  Anokhi J Kapasi; Charles L Clark; Karen Tran; Deborah H Spector
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.